Biomarkers of Diabetes

Biomarkers are molecular markers used as direct or indirect markers of the extent of a disease. HbA1c is considered as the biomarker in diabetes for assessing the risk factor related to retinopathy, nephropathy and other vascular diseases. Biomarkers enable preventive measures to be applied at the subclinical stage and the responses to preventive or therapeutic measures to be monitored.

  • Novel Biomarkers
  • Advances in Molecular Diagnostics
  • HbA1c Biomarker

Related Conference of Biomarkers of Diabetes

July 29-30, 2025

15th World Congress on Endocrinology and Diabetes

Paris, France
September 08-09, 2025

3rd World congress and Expo on Diabetes

Frankfurt, Germany
October 27-28, 2025

5th World Congress on Endocrine and Diabetes

Madrid, Spain
October 30-31, 2025

5th Annual Summit on Diabetes and Endocrinology

Paris, France
November 03-04, 2025

34th European Diabetes Congress

Rome, Italy
November 06-07, 2025

8th Annual Meeting on Diabetes and Endocrinology

Dubai, UAE
November 20-21, 2025

21st World Congress on Endocrinology & Diabetes

Paris, France
November 24-25, 2025

6th International conference on Diabetic complications

Barcelona, Spain
February 23-24, 2026

19th International Summit on Diabetes

London, UK
March 26-27, 2026

7th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands
May 18-19, 2026

57th Annual Congress on Endocrinology and Diabetes Research

Aix-en-Provence, France
September 23-24, 2026

24th Global Conference on Diabetes, Endocrinology and Primary Healthcare

Aix-en-Provence, France

Biomarkers of Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in